|
|
 |
|
Viewing report
|
|
 |
 |
Cardiology, Competitive Strategies, 2002
ADIS, Jan 2002
Cardiology is the largest category of health-care expense in the US - surpassing cancer and infectious diseases by a large margin.
For perspective, the direct and indirect economic costs of cardiovascular diseases and stroke in 2001 are estimated at $298.2 billion in the US, according to the American Heart Association and the National Heart, Lung, and Blood Institute (Nhlbi). Comparable 2001 projections for cancer based on year 2000 National Institutes of Health estimates.
Customers who bought this item also bought
Cardiology Drug Licensing Opportunities, 2002
Immunotherapy in Oncology: Gaining Momentum
Diabetes Competitive Strategies
Competitive Strategies in Dermatology
Competitive Strategies in Pain Management, 2001 Edition
Competitive Strategies in Antiviral Medicine, 2001 Edition
Respiratory Competitive Strategies: Competitive Analysis, Profiles and Portfolio Strategies of the Top 10 Respiratory Therapeutic Manufacturers in the US (2001 Edition)
Optimizing Genomics Asset Management for High ROI - Evaluating Strategies to Support the Bio/Pharma Value Chain
|
 |
|
|